1.Research progress of intramural gallstone
International Journal of Surgery 2012;39(4):270-273
Intramural gallstone is a special kind of gallstone and the mechanism may be related with increasing pressure in gallbladder lumen,inflammation of gallbladder and the formation of Rokitansky-Aschoff sinuses in the gallbladder wall.There is a close relationship between intramural gallstone and lumen stone.Intramural gallstone provides a new challenge to cholecystolithotomy with gallbladder preservation.But study on intramural gallstone may also offer a new idea for the mechanism of gallstone formation.
2.Correlation of insulin levels in diabetic mothers and fetal insulin resistance
Ruiping HUANG ; Fang CAO ; Bin YU ; Ziqiang ZHU ; Ming ZHANG ; Bin ZHANG ; Ye SHI ; Qiuwei WANG
Chinese Journal of General Practitioners 2013;(3):199-201
To explore the relationship between maternal insulin levels and fetal insulin resistance.Maternal blood and venous cord blood samples were collected in gestational diabetes mellitus (GDM) mothers and control subjects.The glucose and insulin levels were measured and insulin resistance levels estimated.Maternal levels of insulin and homeostasis model of assessment for insulin resistance index (HOMAIR) were significantly higher in the GDM group than those in the control group (P < 0.05) ; fetal levels of insulin and HOMA-IR were significantly higher in the GDM group than in the control group (P < 0.05).Maternal insulin level positively correlated with fetal insulin (r =0.326,P < 0.05) and HOMA-IR levels (r =0.378,P <0.05).In this study,a higher level of fetal insulin resistance was reported in the GDM group.And maternal hyperinsulinemia might affect fetal insulin resistance in pregnant women with GDM.
3.Correlation between internal thyroid function and intrahepatic cholestasis in pregnancy
Hong ZHOU ; Qiuwei WANG ; Fang CAO ; Ruiping HUANG ; Ziqiang ZHU ; Dacheng SUN ; Bin YU
Chinese Journal of General Practitioners 2011;10(6):417-419
A total of 166 women with intrahepatic cholestasis in pregnancy (ICP) participated in the study. Serum levels of thyroid stimulating hormone (TSH), free thyroxine 4 (FT4) and thyroid peroxidase antibody (TPOAb) were quantified for all of them with electrochemiluminescence (ECL) technique, and compared with those in normal pregnant women. Results showed that serum TSH and TPOAb [22. 9%(38/166)] increased significantly, but no significant change in serum level of FT4 was observed in women with ICP, as compared to those in normal pregnant women. Overall prevalence of thyroid diseases in ICP women was 35.5% (59/166), significantly higher than that in normal population screened for thyroid disease (17. 1%, 143/837) at the same time period. It suggests that thyroid dysfunction may be involved in pathogenesis of ICP.
4.Significance of pregnancy lipid reference range on the assessment of lipid of gestational diabetes
Fang CAO ; Bin YU ; Ziqiang ZHU ; Ruiping HUANG ; Ye SHI ; Yuqi YANG ; Qiuwei WANG
Chongqing Medicine 2013;(21):2470-2472,2475
Objective To assess lipid status of pregnant women with GDM based on the lipid reference intervals for pregnant women .Methods Maternal blood and venous cord blood samples were collected in 81 well-controlled GDM mothers and 86 control subjects .The total cholesterol (CHOL) ,trigalloyl glycerol (TRIG) ,high-density lipoprotein cholesterol (HDL) ,low-density lipo-protein cholesterol (LDL) ,apolipoprotein A1 (ApoA) ,apolipoprotein B (ApoB) and lipoprotein (a) levels were measured by auto-matic biochemical analyzer .We used a normal pregnancy specific lipid reference interval (PSR) and normal non-pregnant reference intervals (NPR) respectively to assess the lipid status of pregnant women with GDM .Results Compared with normal control group ,the Apo A ,HDL and LDL levels in GDM group were significantly lower (P<0 .05) .The HDL ,LDL and Lp(a) levels of GDM cord blood were significantly lower (P<0 .05) .The weight of offspring birth of GDM pregnant women with low level HDL was significantly higher (P<0 .05) ,and that of GDM pregnant women with high level LDL offspring birth weight was significantly lower (P<0 .05) .Maternal HDL was not correlated with birth weight (r= -0 .190 ,P=0 .103) .Parent LDH and birth weight was negatively correlated (r= -0 .252 ,P=0 .029) .Conclusion The reference range of normal pregnancy-specific lipid we had estab-lished is more scientific for assessment of blood lipids .
5.Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients
Wen-Yue LIU ; Xiaofang ZHANG ; Gang LI ; Liang-Jie TANG ; Pei-Wu ZHU ; Rafael S. RIOS ; Kenneth I. ZHENG ; Hong-Lei MA ; Xiao-Dong WANG ; Qiuwei PAN ; Robert J. DE KNEGT ; Luca VALENTI ; Mohsen GHANBARI ; Ming-Hua ZHENG
Clinical and Molecular Hepatology 2022;28(2):183-195
Background/Aims:
Non-alcoholic fatty liver disease (NAFLD) is closely associated with metabolic dysfunction. Among the multiple factors, genetic variation acts as important modifiers. Klotho, an enzyme encoded by the klotho (KL) gene in human, has been implicated in the pathogenesis of metabolic dysfunctions. However, the impact of variants in KL on NAFLD risk remains poorly understood. The aim of this study was to investigate the impact of KL rs495392 C>A polymorphism on the histological severity of NAFLD.
Methods:
We evaluated the impact of the KL rs495392 polymorphism on liver histology in 531 Chinese with NAFLD and replicated that in the population-based Rotterdam Study cohort. The interactions between the rs495392, vitamin D, and patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 polymorphism were also analyzed.
Results:
Carriage of the rs495392 A allele had a protective effect on steatosis severity (odds ratio [OR], 0.61; 95% confidence interval [CI], 0.42–0.89; P=0.010) in Chinese patients. After adjustment for potential confounders, the A allele remained significant with a protective effect (OR, 0.66; 95% CI, 0.45–0.98; P=0.040). The effect on hepatic steatosis was confirmed in the Rotterdam Study cohort. Additional analysis showed the association between serum vitamin D levels and NAFLD specifically in rs495392 A allele carriers, but not in non-carriers. Moreover, we found that the rs495392 A allele attenuated the detrimental impact of PNPLA3 rs738409 G allele on the risk of severe hepatic steatosis.
Conclusions
The KL rs495392 polymorphism has a protective effect against hepatic steatosis in patients with NAFLD.